Saving the heart in breast cancer treatment — ScienceDaily
Breast cancer patients who are positive for the HER2 gene may be at increased risk for heart damage during chemotherapy, according to a new study published in ecancermedicalscience. Patients with the HER2 gene are often treated with trastuzumab or lapatinib, which interfere with its cancer-causing signals…